<VariationArchive VariationID="53905" VariationName="NM_000492.4(CFTR):c.413_415dup (p.Leu138dup)" VariationType="Duplication" Accession="VCV000053905" Version="19" RecordType="classified" NumberOfSubmissions="10" NumberOfSubmitters="10" DateLastUpdated="2024-06-17" DateCreated="2018-01-25" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="68572" VariationID="53905">
      <GeneList>
        <Gene Symbol="CFTR" FullName="CF transmembrane conductance regulator" GeneID="1080" HGNC_ID="HGNC:1884" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="117480025" stop="117668665" display_start="117480025" display_stop="117668665" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="117120016" stop="117308718" display_start="117120016" display_stop="117308718" Strand="+" />
          </Location>
          <OMIM>602421</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000492.4(CFTR):c.413_415dup (p.Leu138dup)</Name>
      <CanonicalSPDI>NC_000007.14:117531036:CTAC:CTACTAC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7q31.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="117531036" stop="117531037" display_start="117531036" display_stop="117531037" variantLength="3" positionVCF="117531036" referenceAlleleVCF="C" alternateAlleleVCF="CCTA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="117171090" stop="117171091" display_start="117171090" display_stop="117171091" variantLength="3" positionVCF="117171090" referenceAlleleVCF="C" alternateAlleleVCF="CCTA" />
      </Location>
      <OtherNameList>
        <Name>546insCTA oder L138ins</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.117171092_117171094dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.117171092_117171094dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.117531038_117531040dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.117531038_117531040dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016465.4" sequenceAccession="NG_016465" sequenceVersion="4" change="g.70255_70257dup">
            <Expression>NG_016465.4:g.70255_70257dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000492.4" sequenceAccession="NM_000492" sequenceVersion="4" change="c.413_415dup" MANESelect="true">
            <Expression>NM_000492.4:c.413_415dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000483.3" sequenceAccession="NP_000483" sequenceVersion="3" change="p.Leu138dup">
            <Expression>NP_000483.3:p.Leu138dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_663" sequenceAccession="LRG_663">
            <Expression>LRG_663:g.70255_70257dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000492.3" sequenceAccession="NM_000492" sequenceVersion="3" change="c.413_415dupTAC">
            <Expression>NM_000492.3:c.413_415dupTAC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000492.4" sequenceAccession="NM_000492" sequenceVersion="4" change="c.413_415dupTAC" MANESelect="true">
            <Expression>NM_000492.4:c.413_415dupTAC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA327427" DB="ClinGen" />
        <XRef Type="rs" ID="397508686" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000492.4(CFTR):c.413_415dup (p.Leu138dup) AND Cystic fibrosis" Accession="RCV000577362" Version="14">
        <ClassifiedConditionList TraitSetID="1961">
          <ClassifiedCondition DB="MedGen" ID="C0010674">Cystic fibrosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2018-08-31" SubmissionCount="8">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.4(CFTR):c.413_415dup (p.Leu138dup) AND not provided" Accession="RCV001509310" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-02-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000492.4(CFTR):c.413_415dup (p.Leu138dup) AND Bronchiectasis with or without elevated sweat chloride 1" Accession="RCV004566881" Version="1">
        <ClassifiedConditionList TraitSetID="2434">
          <ClassifiedCondition DB="MedGen" ID="C2749757">Bronchiectasis with or without elevated sweat chloride 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-08-31" NumberOfSubmissions="10" NumberOfSubmitters="10" DateCreated="2018-01-25" MostRecentSubmission="2024-06-17">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11589722</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16189704</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20059485</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28340353</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28546993</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30046002</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30548586</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30558651</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32429104</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32992607</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9272157</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://cftr2.org</URL>
        </Citation>
        <DescriptionHistory Dated="2019-06-17">
          <Description>not provided</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1961" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1695" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cystic fibrosis</ElementValue>
                <XRef ID="Cystic+Fibrosis/2071" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009061" DB="MONDO" />
                <XRef Type="MIM" ID="219700" DB="OMIM" />
                <XRef ID="190905008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucoviscidosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CF</ElementValue>
                <XRef Type="MIM" ID="219700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cystic fibrosis (CF) is a multisystem disease affecting epithelia of the respiratory tract, exocrine pancreas, intestine, hepatobiliary system, and exocrine sweat glands. Morbidities include recurrent sinusitis and bronchitis, progressive obstructive pulmonary disease with bronchiectasis, exocrine pancreatic deficiency and malnutrition, pancreatitis, gastrointestinal manifestations (meconium ileus, rectal prolapse, distal intestinal obstructive syndrome), liver disease, diabetes, male infertility due to hypoplasia or aplasia of the vas deferens, and reduced fertility or infertility in some women. Pulmonary disease is the major cause of morbidity and mortality in CF.</Attribute>
                <XRef ID="NBK1250" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000501918" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000209428" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592290" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556536" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569791" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000074114" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000005248" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592286" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508890" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508893" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000277984" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501921" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000025280" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508812" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569983" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330969" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556535" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508894" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569426" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332363" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508811" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000328569" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508810" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592287" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507006" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570317" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508889" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000226639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529460" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521905" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569602" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568279" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000320929" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501920" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508782" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558928" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000004176" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592334" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246717" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569982" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507003" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569790" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569946" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558875" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507950" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514611" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528606" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570019" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6233" />
                <XRef ID="6233" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG/ACOG, 2001">
                <ID Source="PubMed">11280952</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2004">
                <ID Source="pmc">3110945</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301428</ID>
                <ID Source="BookShelf">NBK1250</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2005">
                <ID Source="PubMed">15789152</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPGPT/CF FPT Committees, 2010">
                <ID Source="PubMed">20675678</ID>
              </Citation>
              <Citation Type="general" Abbrev="ECFS, 2010">
                <ID Source="PubMed">20605539</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2009">
                <ID Source="PubMed">19914445</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2009">
                <ID Source="PubMed">19914443</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG ACT Sheets, 2010">
                <ID Source="PubMed">21938795</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2022">
                <URL>https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25</URL>
                <CitationText>DailyMed Drug Label, KALYDECO- ivacaftor tablet, 2022</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG Lab QA, 2002">
                <ID Source="PubMed">12394352</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC, 2012">
                <ID Source="PubMed">22475884</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Accurso et al., 2010">
                <ID Source="pmc">3148255</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2011">
                <ID Source="PubMed">21422883</ID>
              </Citation>
              <Citation Type="general" Abbrev="CPIC, 2014">
                <ID Source="PubMed">24598717</ID>
                <ID Source="pmc">4026598</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">24014130</ID>
              </Citation>
              <Citation Type="general" Abbrev="HGS Australasia, 2014">
                <ID Source="PubMed">25431289</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Wainwright et al., 2015">
                <ID Source="PubMed">25981758</ID>
              </Citation>
              <Citation Type="general" Abbrev="CFF, 2007">
                <ID Source="PubMed">17761616</ID>
              </Citation>
              <Citation Type="general" Abbrev="ECFS, 2018">
                <ID Source="PubMed">29506920</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2020">
                <ID Source="PubMed">32404922</ID>
                <ID Source="pmc">8268680</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Cystic-Fibrosis-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated IRT +/- DNA, Cystic Fibrosis, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2006">
                <URL>https://www.acmg.net/PDFLibrary/IRT_Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Immunoreactive Trypsinogen (IRT Elevated), 2006</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-Mutation-not-R117H.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, CFTR Mutations except R117H, Cystic Fibrosis (CF), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-Mutation-R117H.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, Cystic Fibrosis R117H, 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/CF-No-Mutation.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Carrier Screening ACT Sheet, No Mutations Detected by Carrier Screening, Cystic Fibrosis (CF), 2012</CitationText>
              </Citation>
              <XRef ID="586" DB="Orphanet" />
              <XRef ID="C0010674" DB="MedGen" />
              <XRef ID="MONDO:0009061" DB="MONDO" />
              <XRef Type="MIM" ID="219700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2434" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1065" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Bronchiectasis with or without elevated sweat chloride 1</ElementValue>
                <XRef ID="MONDO:0008887" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystic Fibrosis-Like Syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BESC1</ElementValue>
                <XRef Type="MIM" ID="211400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18054" />
                <XRef ID="18054" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="60033" DB="Orphanet" />
              <XRef ID="C2749757" DB="MedGen" />
              <XRef ID="MONDO:0008887" DB="MONDO" />
              <XRef Type="MIM" ID="211400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1331076" SubmissionDate="2013-03-30" DateLastUpdated="2018-01-25" DateCreated="2018-01-25">
        <ClinVarSubmissionID localKey="NM_000492.3:c.414_415insCTA|CFTR-related disorders" />
        <ClinVarAccession Accession="SCV000679461" DateUpdated="2018-01-25" DateCreated="2018-01-25" Type="SCV" Version="1" SubmitterName="ClinVar Staff, National Center for Biotechnology Information (NCBI)" OrgID="500139" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.414_415insCTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CFTR-related disorders</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <ID Source="PubMed">20059485</ID>
        </Citation>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2869290" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_000492.3:c.413_415dupTAC|Cystic Fibrosis" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001454015" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.413_415dupTAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cystic Fibrosis</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5032625" SubmissionDate="2022-09-06" DateLastUpdated="2022-09-24" DateCreated="2022-09-24">
        <ClinVarSubmissionID localKey="CFTR_SiA_96|OMIM:219700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002574101" DateUpdated="2022-09-24" DateCreated="2022-09-24" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>This variant was identified in 4 unrelated patients with a clinically confirmed diagnosis of cystic fibrosis. The variant was classified in the context of a project re-classifying variants in the German Cystic Fibrosis Registry (Muko.e.V.). Link: https://www.muko.info/angebote/qualitaetsmanagement/register/cf-einrichtungen/mukoweb. Criteria applied: PS3_SUP, PM2_SUP, PM3_STR, PM4_SUP, PP4</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="4" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>546insCTA oder L138ins</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.4:c.413_415dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="219700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12016701</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3108810" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="2842582|MedGen:C0010674" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001583173" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9272157</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16189704</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28546993</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30548586</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30046002</ID>
          </Citation>
          <Comment>This variant, c.413_415dup, results in the insertion of 1 amino acid(s) of the CFTR protein (p.Leu138dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs752803445, gnomAD 0.004%). This variant has been observed in individual(s) with CFTR-related conditions (PMID: 9272157, 16189704, 28546993, 30548586). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as 546insCTA and c.411_412insCTA. ClinVar contains an entry for this variant (Variation ID: 53905). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects CFTR function (PMID: 30046002). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.117171090_117171091insCTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0010674" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9000541" SubmissionDate="2024-03-27" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="NylqsEYAai4/3fxzdvN/8tVH6O86FKYn90ttfw==|OMIM:219700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004814226" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="North West Genomic Laboratory Hub, Manchester University NHS Foundation Trust" OrgID="283808" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Criteria Codes: PM2 PM3_VStr PM4</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.117171092_117171094dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="219700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14342031</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9817448" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_000492.4:c.413_415dup|OMIM:211400" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005057460" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.4:c.413_415dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="211400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1803814" SubmissionDate="2019-03-21" DateLastUpdated="2019-06-17" DateCreated="2019-06-17">
        <ClinVarSubmissionID localKey="L138ins|Cystic fibrosis" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000924246" DateUpdated="2019-06-17" DateCreated="2019-06-17" Type="SCV" Version="1" SubmitterName="CFTR2" OrgID="500092" OrganizationCategory="locus-specific database (LSDB)" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-31">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://cftr2.org</URL>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Sosnay PR et al. (Nat Genet 2013)</Attribute>
          <Citation>
            <ID Source="PubMed">23974870</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Leu138dup</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.413_415dupTAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cystic fibrosis</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5349662</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3376369" SubmissionDate="2021-05-26" DateLastUpdated="2021-06-15" DateCreated="2021-06-15">
        <ClinVarSubmissionID localKey="NM_000492.3:c.413_415dupTAC|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001715936" DateUpdated="2021-06-15" DateCreated="2021-06-15" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32429104</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30548586</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32992607</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28546993</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30046002</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11589722</ID>
          </Citation>
          <Comment>PS3, PS4_Moderate, PM2, PM3, PM4, PP5</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000492.3:exon 4</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Leu138dup</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.413_415dupTAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9741791</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2645609" SubmissionDate="2024-04-03" DateLastUpdated="2024-04-15" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="NM_000492.4:c.413_415dupTAC|MedGen:C0010674" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001338283" DateUpdated="2024-04-15" DateCreated="2020-06-22" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9272157</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11589722</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16189704</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28546993</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30046002</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30548586</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30558651</ID>
          </Citation>
          <Comment>Variant summary: CFTR c.413_415dupTAC (p.Leu138dup) results in an in-frame duplication that is predicted to duplicate 1 amino acids into the encoded protein. The variant allele was found at a frequency of 4e-06 in 250744 control chromosomes. c.413_415dupTAC has been reported in the literature in multiple individuals affected with Cystic Fibrosis (e.g. Behar_2017, Guo_2018, McGinniss_2005, Petrova_2019, Walkowiak_2001). These data indicate that the variant is very likely to be associated with disease. Experimental evidence evaluating an impact on protein function demonstrated the variant confers residual function 1.6% of wild-type (Han_2018). The following publications have been ascertained in the context of this evaluation (PMID: 9272157, 11589722, 16189704, 28546993, 30046002, 30548586, 30558651).ClinVar contains an entry for this variant (Variation ID: 53905). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.4:c.413_415dupTAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0010674" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14342304</SubmissionName>
          <SubmissionName>SUB7346674</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5113401" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a59096|MedGen:C0010674" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002628550" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28340353</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28546993</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30046002</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9272157</ID>
          </Citation>
          <Comment>The c.413_415dupTAC pathogenic mutation (also known as p.L138dup), located in coding exon 4 of the CFTR gene, results from an in-frame duplication of TAC at nucleotide positions 413 to 415. This results in the duplication of an extra residue between codons 138 and 139. In our laboratory, this variant has been detected in trans with a pathogenic mutation in CFTR in an individual with intermediate sweat chloride levels (Ambry internal data). In an analysis of 40 CFTR mutations in Russian cystic fibrosis (CF) patients, this variant (reported as L138ins) was detected in 1.8% of the chromosomes (Adyan TA et al. Russ J Genet, 2018 Oct;54:1235-1244). This mutation was reported in a Polish male with congenital bilateral absence of the vas deferens (CBAVD) in conjunction with a 5T allele (D&amp;ouml;rk T et al. Hum. Genet., 1997 Sep;100:365-77). This alteration was also described in an individual with CF in conjunction with the c.3717+12191C&gt;T mutation; however, the phase is unclear (Behar DM et al. Mol Genet Genomic Med, 2017 May;5:223-236). Based on internal structural analysis, this pathogenic variant is anticipated to result in a significant decrease in structural stability (Liu F et al. Cell, 2017 Mar;169:85-95.e8). In addition, human CF bronchial epithelial (CFBE) cells stably expressing this mutation (reported as L138ins) had only 1.6% of CFTR function, compared to cells expressing wild-type CFTR protein (Han ST et al. JCI Insight, 2018 Jul;3:). Furthermore, the duplication has an overall frequency of approximately 0.0004% (1/250744) in the Genome Aggregation Database (gnomAD) (Lek M et al. Nature, 2016 08;536:285-91). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CFTR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000492.3:c.413_415dupTAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0010674" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9000541" TraitType="Disease" MappingType="XRef" MappingValue="219700" MappingRef="OMIM">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3108810" TraitType="Disease" MappingType="XRef" MappingValue="C0010674" MappingRef="MedGen">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1331076" TraitType="Disease" MappingType="Name" MappingValue="CFTR-related disorders" MappingRef="Preferred">
        <MedGen CUI="None" Name="CFTR-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2869290" TraitType="Disease" MappingType="Name" MappingValue="Cystic Fibrosis" MappingRef="Preferred">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2645609" TraitType="Disease" MappingType="XRef" MappingValue="C0010674" MappingRef="MedGen">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3376369" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9817448" TraitType="Disease" MappingType="XRef" MappingValue="211400" MappingRef="OMIM">
        <MedGen CUI="C2749757" Name="Bronchiectasis with or without elevated sweat chloride 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5032625" TraitType="Disease" MappingType="XRef" MappingValue="219700" MappingRef="OMIM">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5113401" TraitType="Disease" MappingType="XRef" MappingValue="C0010674" MappingRef="MedGen">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1803814" TraitType="Disease" MappingType="Name" MappingValue="Cystic fibrosis" MappingRef="Preferred">
        <MedGen CUI="C0010674" Name="Cystic fibrosis" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="2" DateDeleted="2017-12-11">SCV000075103</Accession>
        <Description>this interpretation was deleted because it was generated with an out-of-date curation method; no clinical information is available to provide a full interpretation of the variant</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

